SEARCH

SEARCH BY CITATION

References

  • Andersen G, Harnack K, Erbersdobler HF, Somoza V (2008). Dietary eicosapentaenoic acid and docosahexaenoic acid are more effective than alpha-linolenic acid in improving insulin sensitivity in rats. Ann Nutr Metab 52: 250256.
  • Aoki H, Hisada T, Ishizuka T, Utsugi M, Kawata T, Shimizu Y et al. (2008). Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun 367: 509515.
  • Ariel A, Fredman G, Sun YP, Kantarci A, Van Dyke TE, Luster AD et al. (2006). Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol 7: 12091216.
  • Ariel A, Li PL, Wang W, Tang WX, Fredman G, Hong S et al. (2005). The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering. J Biol Chem 280: 4307943086.
  • Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S et al. (2005a). Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201: 713722.
  • Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA et al. (2005b). Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci USA 102: 76717676.
  • Arita M, Oh SF, Chonan T, Hong S, Elangovan S, Sun YP et al. (2006). Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. J Biol Chem 281: 2284722854.
  • Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, Serhan CN (2007). Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 178: 39123917.
  • Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH et al. (2005). Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol 174: 43454355.
  • Brink C, Dahlen SE, Drazen J, Evans JF, Hay DW, Nicosia S et al. (2003). International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol Rev 55: 195227.
  • Burr GO, Burr MM (1929). A new deficiency disease produced by the rigid exclusion of fat from the diet. J Biol Chem 82: 345367.
  • Campbell EL, Louis NA, Tomassetti SE, Canny GO, Arita M, Serhan CN et al. (2007). Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J 21: 31623170.
  • Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J et al. (2008). Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med 205: 767775.
  • Cezar-de-Mello PF, Vieira AM, Nascimento-Silva V, Villela CG, Barja-Fidalgo C, Fierro IM (2008). ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor. Br J Pharmacol 153: 956965.
  • Claria J, Serhan CN (1995). Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 92: 94759479.
  • Claria J, Lee MH, Serhan CN (1996). Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol Med 2: 583596.
  • Cotran RVK, Collins T (1999). Robbins Pathologic Basis of Disease. Saunders: Philadelphia.
  • Das UN (2008). Can essential fatty acids reduce the burden of disease(s)? Lipids Health Dis 7: 9.
  • Devchand PR, Arita M, Hong S, Bannenberg G, Moussignac RL, Gronert K et al. (2003). Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. Faseb J 17: 652659.
  • Dona M, Fredman G, Schwab JM, Chiang N, Arita M, Goodarzi A et al. (2008). Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 112: 848855.
  • Duffield JS, Hong S, Vaidya VS, Lu Y, Fredman G, Serhan CN et al. (2006). Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 177: 59025911.
  • Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R et al. (2004). Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 350: 2937.
  • Filep JG, Zouki C, Petasis NA, Hachicha M, Serhan CN (1999). Anti-inflammatory actions of lipoxin A(4) stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions. Blood 94: 41324142.
  • Fiore S, Serhan CN (1990). Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils. J Exp Med 172: 14511457.
  • Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK et al. (2004). Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 350: 560569.
  • Freedman SD, Katz MH, Parker EM, Laposata M, Urman MY, Alvarez JG (1999). A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice. Proc Natl Acad Sci USA 96: 1399514000.
  • Fukunaga K, Kohli P, Bonnans C, Fredenburgh LE, Levy BD (2005). Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J Immunol 174: 50335039.
  • Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE et al. (1999). Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 27: 14091420.
  • Gilroy DW, Lawrence T, Perretti M, Rossi AG (2004). Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 3: 401416.
  • GISSI investigators (1999). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354: 447455.
  • Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR (2000). Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol 164: 16631667.
  • Gonzalez-Periz A, Planaguma A, Gronert K, Miquel R, Lopez-Parra M, Titos E et al. (2006). Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J 20: 25372539.
  • Gronert K, Kantarci A, Levy BD, Clish CB, Odparlik S, Hasturk H et al. (2004). A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage. J Immunol 172: 18561861.
  • Gronert K, Maheshwari N, Khan N, Hassan IR, Dunn M, Laniado Schwartzman M (2005). A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem 280: 1526715278.
  • Haslett C (1992). Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci (Lond) 83: 639648.
  • Hasturk H, Kantarci A, Goguet-Surmenian E, Blackwood A, Andry C, Serhan CN et al. (2007). Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol 179: 70217029.
  • Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N et al. (2006). RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis. FASEB J 20: 401403.
  • Haworth O, Cernadas M, Yang R, Serhan CN, Levy BD (2008). Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A(4) to promote the resolution of allergic airway inflammation. Nat Immunol 9: 873879.
  • Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN (2003). Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem 278: 1467714687.
  • Hong S, Porter TF, Lu Y, Oh SF, Pillai PS, Serhan CN (2008). Resolvin E1 metabolome in local inactivation during inflammation-resolution. J Immunol 180: 35123519.
  • Hudert CA, Weylandt KH, Lu Y, Wang J, Hong S, Dignass A et al. (2006). Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci USA 103: 1127611281.
  • Iso H, Rexrode KM, Stampfer MJ, Manson JE, Colditz GA, Speizer FE et al. (2001). Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 285: 304312.
  • Jacobson JL, Jacobson SW, Muckle G, Kaplan-Estrin M, Ayotte P, Dewailly E (2008). Beneficial effects of a polyunsaturated fatty acid on infant development: evidence from the inuit of arctic Quebec. J Pediatr 152: 356364.
  • Lawrence T, Bebien M, Liu GY, Nizet V, Karin M (2005). IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434: 11381143.
  • Lee TH, Mencia-Huerta JM, Shih C, Corey EJ, Lewis RA, Austen KF (1984). Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest 74: 19221933.
  • Levy BD, Fokin VV, Clark JM, Wakelam MJ, Petasis NA, Serhan CN (1999). Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a ‘stop’ signaling switch for aspirin-triggered lipoxin A4. Faseb J 13: 903911.
  • Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN (2001). Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2: 612619.
  • Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt BA et al. (2002). Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med 8: 10181023.
  • Levy BD, Kohli P, Gotlinger K, Haworth O, Hong S, Kazani S et al. (2007a). Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol 178: 496502.
  • Levy BD, Lukacs NW, Berlin AA, Schmidt B, Guilford WJ, Serhan CN et al. (2007b). Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism. FASEB J 21: 38773884.
  • Lu Y, Hong S, Tjonahen E, Serhan CN (2005). Mediator-lipidomics: databases and search algorithms for PUFA-derived mediators. J Lipid Res 46: 790802.
  • Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K et al. (2005). A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115: 27742783.
  • Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A et al. (2003). Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 278: 4380743817.
  • Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R et al. (2002). Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105: 18971903.
  • Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG (2004). Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 101: 84918496.
  • Mukherjee PK, Chawla A, Loayza MS, Bazan NG (2007a). Docosanoids are multifunctional regulators of neural cell integrity and fate: significance in aging and disease. Prostaglandins Leukot Essent Fatty Acids 77: 233238.
  • Mukherjee PK, Marcheselli VL, Barreiro S, Hu J, Bok D, Bazan NG (2007b). Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling. Proc Natl Acad Sci USA 104: 1315213157.
  • Nagakura T, Matsuda S, Shichijyo K, Sugimoto H, Hata K (2000). Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J 16: 861865.
  • Nathan C (2002). Points of control in inflammation. Nature 420: 846852.
  • Pacht ER, DeMichele SJ, Nelson JL, Hart J, Wennberg AK, Gadek JE (2003). Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med 31: 491500.
  • Perretti M, Chiang N, La M, Fierro IM, Marullo S, Getting SJ et al. (2002). Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med 8: 12961302.
  • Rossi AG, Sawatzky DA, Walker A, Ward C, Sheldrake TA, Riley NA et al. (2006). Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med 12: 10561064.
  • Samuelsson B (1982). From studies of biochemical mechanisms to novel biological mediators: prostaglandin endoperoxides, thromboxanes and leukotrienes. In: W Odelberg (ed.). Les Prix Nobel: Nobel Prizes, Presentations, Biographies and Lectures. Almqvist & Wiksell: Stockholm, pp. 153174.
  • Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C (1989). Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83: 865875.
  • Schottelius AJ, Giesen C, Asadullah K, Fierro IM, Colgan SP, Bauman J et al. (2002). An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile. J Immunol 169: 70637070.
  • Schwab JM, Chiang N, Arita M, Serhan CN (2007). Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447: 869874.
  • Serhan CN, Chiang N (2008). Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol 153: S200S215.
  • Serhan CN, Chiang N, Van Dyke TE (2008). Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349361.
  • Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K (2000). Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192: 11971204.
  • Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G et al. (2002). Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196: 10251037.
  • Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B et al. (2003). Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 171: 68566865.
  • Serhan CN, Gotlinger K, Hong S, Arita M (2004). Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat 73: 155172.
  • Serhan CN, Gotlinger K, Hong S, Lu Y, Siegelman J, Baer T et al. (2006). Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol 176: 18481859.
  • Serhan CN, Lu Y, Hong S, Yang R (2007). Mediator lipidomics: search algorithms for eicosanoids, resolvins, and protectins. Methods Enzymol 432: 275317.
  • Shen J, Herderick E, Cornhill JF, Zsigmond E, Kim H.-S., Kuhn H et al. (1996). Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 98: 22012208.
  • Sodin-Semrl S, Taddeo B, Tseng D, Varga J, Fiore S (2000). Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol 164: 26602666.
  • Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, Campbell E et al. (2007). Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem 282: 93239334.
  • Takano T, Fiore S, Maddox JF, Brady HR, Petasis NA, Serhan CN (1997). Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med 185: 16931704.
  • Takano T, Clish CB, Gronert K, Petasis N, Serhan CN (1998). Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. J Clin Invest 101: 819826.
  • Tjonahen E, Oh SF, Siegelman J, Elangovan S, Percarpio KB, Hong S et al. (2006). Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Chem Biol 13: 11931202.
  • Uller L, Persson CG, Erjefalt JS (2006). Resolution of airway disease: removal of inflammatory cells through apoptosis, egression or both? Trends Pharmacol Sci 27: 461466.
  • Van Biervliet S, Devos M, Delhaye T, Van Biervliet JP, Robberecht E, Christophe A (2008). Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients. Prostaglandins Leukot Essent Fatty Acids 78: 109115.
  • Vedin I, Cederholm T, Freund Levi Y, Basun H, Garlind A, Faxen Irving G et al. (2008). Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study. Am J Clin Nutr 87: 16161622.
  • Walser B, Stebbins CL (2008). Omega-3 fatty acid supplementation enhances stroke volume and cardiac output during dynamic exercise. Eur J Appl Physiol 104: 455461.
  • Winyard PG and Willoughby (eds) (2003). Inflammation Protocols. Methods in molecular biology, Volume 225. Humana Press, Totowa, NJ.
  • Xia S, Lu Y, Wang J, He C, Hong S, Serhan CN et al. (2006). Melanoma growth is reduced in fat-1 transgenic mice: impact of omega-6/omega-3 essential fatty acids. Proc Natl Acad Sci USA 103: 1249912504.